Friday May 25 | BioSpace
ICON Presents Successful Late Phase, Outcomes Research and Pricing Strategies at
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Dublin, Ireland, 25 May 2012 - ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today ... (more)
ICON Reports a 10% Increase in First Quarter 2012 Revenue to $252...
ICON Reports a 10% Increase in First Quarter 2012 Revenue to $252 Million, Up 10% Year on Year, EPS of 15 Cents, Net New Business Awards of $385 Million and a B:B of 1.5 Dublin, Ireland, April 24, 2012 - ICON , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported ... (more)
ICON Release: Nimble Approach to Partnerships Will Generate Value for ...
ICON Release: Nimble Approach to Partnerships Will Generate Value for Both CROs and the Pharmaceutical Industry, According to New Study Dublin, Ireland, and New York, USA, 10 April, 2012 - As more and more R&D is outsourced by pharmaceutical companies, a study released today provides new insight into how to structure the relevant partnerships for ... (more)